Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Pfizer buys immune system specialists Coley

November 22, 2007 Research and Development

Pfizer is to acquire a company developing new drugs that fight diseases by altering the immune system. The company is …
News

GSK pays $1.65 billion for cardiovascular specialists Reliant

November 22, 2007 Research and Development

News

Latest news from Datamonitor

November 20, 2007 Research and Development

Aeterna completes enrollment for Phase II trial of lung cancerAeterna Zentaris has completed patient recruitment for its European multi-center Phase …
News

A meeting of minds: working with academia

November 9, 2007 Research and Development, Sales and Marketing academia, partnerships, pharma

Feature

CROs included in clinical trials fast track

November 2, 2007 Research and Development

Efforts to cut unnecessary delays to UK clinical trials have taken a step forward with a new agreement to help …
News

Redefining pharmaceutical CRM

October 24, 2007 Research and Development, Sales and Marketing CRM, customer relationship management, sales

Fierce generic competition, price containment regulations and poor pipeline productivity are challenges looming over many pharmaceutical companies today. In effect, …
Feature

Latest news from Datamonitor

October 24, 2007 Research and Development

Abraxis gets FDA approval for chemotherapy drugAbraxis Pharmaceutical Products, the hospital-based business of Abraxis BioScience, has received FDA approval to …
News

Latest news from Datamonitor

October 18, 2007 Research and Development

Advaxis cancer vaccine shows encouraging resultsBiotechnology company Advaxis has announced positive results from a Phase I/II first-in-man trial of a …
News

Pfizer to set up separate biotech arm

October 11, 2007 Research and Development

Pfizer has unveiled its new strategy in research and development, including senior appointments and the setting up of an independent …
News

Gates Foundation invests $100m in unorthodox research

October 10, 2007 Research and Development

Scientists with novel ideas for research into some of the world's biggest diseases are to be offered a new source …
News

Latest news from Datamonitor

October 9, 2007 Research and Development

Critical Therapeutics starts Phase I trial of zileutonCritical Therapeutics has initiated a phase I clinical trial to assess the safety …
News

Wyeth buys Scottish biotech firm

October 8, 2007 Research and Development

Wyeth is to acquire Haptogen, a biotech research company based in Aberdeen which has a unique approach to targeting the …
News

Latest news from Datamonitor

October 1, 2007 Research and Development

Cubicin approved for marketing in CanadaCubist Pharmaceuticals has said that Health Canada has approved Cubicin for marketing in Canada, where …
News

Leukaemia drug enters phase III studies in MS

September 28, 2007 Research and Development

Patients with multiple sclerosis could benefit from a drug currently used to treat leukaemia, with late-stage trials now commencing.Discovered by …
News

BMS makes $430m biotech acquisition

September 27, 2007 Research and Development

Bristol-Myers Squibb has significantly advanced its strategy to move into biologics with the acquisition of US biotech Adnexus.The $430 million …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026